Header Logo

Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia.

Patel SA. Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia. JAMA Oncol. 2018 08 01; 4(8):1110-1111.

View in: PubMed